Cambridge Investment Research Advisors
GEHC icon

Cambridge Investment Research Advisors’s GE HealthCare GEHC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.27M Sell
82,290
-2,983
-3% -$196K 0.01% 1011
2026
Q1 		$6.07M Buy
85,273
+2,112
+3% +$167K 0.02% 861
2025
Q4 		$6.82M Sell
83,161
-2,413
-3% -$188K 0.02% 761
2025
Q3 		$6.43M Sell
85,574
-10,190
-11% -$760K 0.02% 769
2025
Q2 		$7.09M Sell
95,764
-2,951
-3% -$205K 0.02% 686
2025
Q1 		$7.97M Sell
98,715
-11,607
-11% -$998K 0.03% 593
2024
Q4 		$8.63M Buy
110,322
+4,021
+4% +$342K 0.03% 545
2024
Q3 		$9.98M Sell
106,301
-4,775
-4% -$401K 0.03% 502
2024
Q2 		$8.65M Buy
111,076
+13,456
+14% +$1.1M 0.03% 527
2024
Q1 		$8.88M Buy
97,620
+493
+0.5% +$41K 0.03% 501
2023
Q4 		$7.51M Buy
97,127
+18,634
+24% +$1.3M 0.03% 530
2023
Q3 		$5.34M Buy
78,493
+32,051
+69% +$2.33M 0.02% 617
2023
Q2 		$3.77M Buy
46,442
+5,346
+13% +$427K 0.02% 803
2023
Q1 		$3.37M Buy
+41,096
New +$2.93M 0.02% 826

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Cambridge Investment Research Advisors's GEHC Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its GE HealthCare (GEHC) stake by 3.5% in Q2 2026, selling an estimated $196K and leaving 82,290 shares worth $5.27M. The position accounts for 0.01% of the portfolio, ranked #1011.

Cambridge Investment Research Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $9.98M in Q3 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Cambridge Investment Research Advisors held 82,290 shares of GE HealthCare worth $5.27M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 2,983 GE HealthCare shares in Q2 2026, an estimated $196K.
  • GE HealthCare made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1011 holding.
  • Cambridge Investment Research Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Cambridge Investment Research Advisors's GE HealthCare position peaked at $9.98M in Q3 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.